Received Feb 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
pneumonia related COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 PNEUMONIA (pneumonia related COVID) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced COVID-19 PNEUMONIA (pneumonia related COVID) (seriousness criterion medically significant). At the time of the report, COVID-19 PNEUMONIA (pneumonia related COVID) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. Concomitant medication was not reported. It was stated that she had only received Moderna COVID vaccines and not had a booster in a while, and in August reported having had pneumonia related COVID. It was stated that she wanted to get another COVID booster by Moderna and did not want to switch to Pfizer. No additional information was provided. It was unknown if the patient experienced any additional symptoms/events. Treatment medication was not reported.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.